Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Celadon Pharmaceuticals Plc | LSE:CEL | London | Ordinary Share | GB00BDQYGP38 | ORD 1P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | |
|---|---|---|---|---|---|
| -1.75 | -11.29% | 13.75 | 12.00 | 13.00 |
| High Price | Low Price | Open Price | Shares Traded | Last Trade |
|---|---|---|---|---|
| 15.50 | 12.50 | 15.50 | 332,250 | 16:35:22 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Pharmaceutical Preparations | 149k | -7.14M | -0.1078 | -1.16 | 10.26M |
| Date | Time | Source | Headline |
|---|---|---|---|
| 18/11/2024 | 12:59 | ALNC |  Celadon shares slump on little progress in financing talks |
| 18/11/2024 | 07:00 | UK RNS | Celadon Pharmaceuticals PLC Update on Financial Position |
| 04/10/2024 | 12:00 | UK RNS | Celadon Pharmaceuticals PLC Investor Site Visit – Tuesday 22 October 2024 |
| 02/10/2024 | 17:32 | ALNC | Celadon Pharmaceuticals signs sales contract with Valeos Pharma |
| 02/10/2024 | 06:00 | UK RNS | Celadon Pharmaceuticals PLC New Sales Contract with a Healthcare Company |
| 30/9/2024 | 13:07 | ALNC | EXECUTIVE CHANGES: Bank of Ireland promotes ex-Barclays exec to chair |
| 30/9/2024 | 06:05 | UK RNS | Celadon Pharmaceuticals PLC Departure of Chief Financial Officer |
| 30/9/2024 | 06:00 | UK RNS | Celadon Pharmaceuticals PLC Interim Results |
| 17/9/2024 | 08:28 | UK RNS | Celadon Pharmaceuticals PLC Admission of Shares and Total Voting Rights |
| 11/9/2024 | 12:54 | ALNC | Celadon Pharmaceuticals shares dive as laments delayed funding |
1 Year Celadon Pharmaceuticals Chart |
Intraday Celadon Pharmaceuticals Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
